Abstract
In vitro tumour models utilise various cancer cells and an appropriate extracellular matrix equivalent to recapitulate the in vivo tumour microenvironment. Three-dimensional tissue surrogates (e.g., decellularised tissue grafts, decellularised monolayers, hydrogels, electrospun fibres and sponges) are increasingly used as alternatives to conventional two-dimensional monolayer cultures to model the tissue environment more faithfully for drug development and screening. Herein, we critically assess the advances and shortfalls of these three-dimensional systems as in vitro models of cancer.
| Original language | English (Ireland) |
|---|---|
| Journal | Drug Discovery Today |
| Volume | 21 |
| Issue number | 9 |
| Publication status | Published - 1 Sep 2016 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Authors (Note for portal: view the doc link for the full list of authors)
- Authors
- Shologu, N., Szegezdi, E., Lowery, A., Kerin, M., Pandit, A. and Zeugolis, D.I.
Fingerprint
Dive into the research topics of 'Recreating Complex Pathophysiologies In Vitro with Extracellular Matrix Surrogates for Anticancer Therapeutics Screening In Vitro Cancer Models with ECM Surrogates'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver